E
2.53
-0.04 (-1.37%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Elicio Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.4
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.36 |
|
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 43.87% |
| 机构持股比例 | 10.26% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Knoll Capital Management, Llc | 30 Jun 2026 | 1,211,957 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合